Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
1	1 Cabaletta Bio CABA $157M	1,107% upside 3 price targets	0
2	2 Immunic IMUX $79.5M	904% upside 3 price targets	0
3	3 4D Molecular Therapeutics FDMT $198M	733% upside 3 price targets	0
4	4 Clene CLNN $32.2M	699% upside 3 price targets	0
5	5 Adverum Biotechnologies ADVM $53.1M	678% upside 4 price targets	0
6	6 Jasper Therapeutics JSPR $52.7M	608% upside 7 price targets	0
7	7 Biomea Fusion BMEA $114M	583% upside 3 price targets	0
8	8 Esperion Therapeutics ESPR $236M	544% upside 3 price targets	0
9	9 Aclaris Therapeutics ACRS $170M	521% upside 4 price targets	0
10	10 Corbus Pharmaceuticals CRBP $101M	521% upside 3 price targets	0
11	11 Karyopharm Therapeutics KPTI $39.3M	515% upside 4 price targets	0
12	12 Protara Therapeutics TARA $118M	512% upside 3 price targets	0
13	13 Korro Bio KRRO $119M	468% upside 4 price targets	0
14	14 Inovio Pharmaceuticals INO $49.9M	464% upside 3 price targets	0
15	15 Clearside Biomedical CLSD $68.8M	390% upside 3 price targets	0
16	16 Lucid Diagnostics LUCD $123M	273% upside 3 price targets	0
17	17 PolyPid PYPD $34.4M	248% upside 4 price targets	0
18	18 Lexeo Therapeutics LXEO $241M	236% upside 3 price targets	0
19	19 ProQR Therapeutics PRQR $244M	223% upside 4 price targets	0
20	20 Y-mAbs Therapeutics YMAB $197M	206% upside 3 price targets	0
21	21 Immuneering IMRX $159M	200% upside 4 price targets	0
22	22 Coya Therapeutics COYA $103M	169% upside 4 price targets	0
23	23 Prairie Operating Co PROP $153M	163% upside 5 price targets	0
24	24 Leslie's LESL $77.6M	159% upside 3 price targets	0
25	ADAP 25 Adaptimmune Therapeutics ADAP $71.2M	143% upside 3 price targets	0

12